ReviewJournal of cancer survivorship : research and practice2026
Survivorship care for melanoma patients: a scoping review.
Review in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDespite significant advances in melanoma treatment, many survivors continue to experience long-term effects of disease and therapy. Various survivorship care programs have been developed in recent years, but these differ in terms of their scope, content, and delivery. The aim of this scoping review was to summarize existing literature on melanoma survivorship care.
methodsThe search strategy was developed using the PCC (Population, Concept, Context) framework for scoping reviews. We conducted systematic searches in MEDLINE®, the Cochrane Library, Web of Science and CINAHL for studies published between 01/2015 and 03/2026. Additionally, the reference lists of the included studies were screened. Two researchers conducted the searches independently. They screened the studies using defined criteria and extracted data on study characteristics and the reported care. The results were summarized using the content analysis by Elo and Kyngäs.
resultsOf the 2,993 references screened, 21 studies met the inclusion criteria and covered seven unique survivorship care programs. These studies were published from 2015 onward. Using the domains of the Cancer survivorship care quality framework, we characterized the studies as follows: prevention and monitoring of recurrence and new cancers; monitoring and management of physical, psychosocial, and chronic conditions; health promotion and disease prevention; and context-related domains of the healthcare system, such as clinical structure, communication and decision making, and care coordination.
conclusionThis scoping review summarizes the current melanoma survivorship care. Evidence gaps remain, particularly regarding health literacy and health economic perspectives. IMPLICATION FOR CANCER SURVIVORS: The findings will support the development of a patient-centered survivorship care program for people living with and beyond melanoma.
Indexed as
Identifiers
42690604What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.